Thrombin clotting time

Methods in Molecular Biology

Volumn 992, Issue , 2013, Pages 131-138

  Ignjatovic, Vera ^a,b  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Coagulation test; TCT; TT

Indexed keywords

FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; HEPARIN; HEPARIN LYASE; HIRUDIN; RISTOCETIN; THROMBIN;

AFIBRINOGENEMIA; ARTICLE; BLOOD CLOTTING TEST; BLOOD SAMPLING; DIAGNOSTIC ACCURACY; DYSFIBRINOGENEMIA; HUMAN; HYPOFIBRINOGENEMIA; PARTIAL THROMBOPLASTIN TIME; PATIENT MONITORING; PRIORITY JOURNAL; REFERENCE VALUE; STANDARDIZATION; THROMBIN TIME;

EID: 84877117204     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-339-8_10     Document Type: Article

References (17)

1. Clauss VA (1957) Gerinnungsphysiologische schnell methode zur bestimmun des fi brinogens. Acta Haematol 17:237-246
2. Flanders MM, Crist R, Rodgers GM (2003) Comparison of fi ve thrombin time reagents. Clin Chem 49:169-172
3. Bockenstedt PL (1998) Laboratory methods in hemostasis. In: Loscalzo J, Schafer AI (eds) Thrombosis and hemorrhage, 2nd edn. Williams and Wilkins, Baltimore, pp 517-580
4. Ts'ao CH, Raymond J, Kolb T, Lo R (1976) Effects of source and concentration of thrombin, and divalent cations, on thrombin time of heparinized plasma. Am J Clin Pathol 65: 206-212
5. Ray MJ, Perrin EJ, Smith IR, Hawson GA (1996) A proposed model to monitor heparin therapy using the concentrated thrombin time which allows standardisation of reagents and improved estimation of heparin concentrations. Blood Coag Fibrinol 7:515-521
6. Chan A, Black L, Ing C, Williams S, Brandao L, Walter K, Abdelhaleem M (2005) Utility of aPTT in monitoring unfractionated heparin in children. J Thromb Haemost 3, abstract OR360.
7. Reid TJR, Alving BM (1993) A quantitative thrombin time for determining levels of hirudin and hirulog. Thromb Haemost 70: 608-616
8. Shore-Lesserson L, Manspeizer HE, Bolastig M, Harrington D, Vela-Cantos F, DePerio M (2000) Anticoagulation for cardiac surgery in patients receiving preoperative heparin: Use of high-dose thrombin time. Anaesth Analg 90:813-818
9. Wang JS, Lin C, Karp RB (1994) Comparison of high-dose thrombin time with activated clotting time for monitoring of anticoagulant effects of heparin in cardiac surgical patients. Anaesth Analg 79:9-13
10. Love JE, Ferrell C, Chandler WL (2007) Monitoring direct thrombin inhibitors with a plasma diluted thrombin time. Thromb Haemost 98:234-242
11. Monagle P, Barnes C, Ignjatovic V, Furmedge J, Newall F, Chan A, De Rosa L, Hamilton S, Ragg P, Robinson S, Auldist A, Crock C, Roy N, Rowlands S (2006) Developmental haemostasis: Impact for clinical haemostasis laboratories. Thromb Haemost 95:362-372
12. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, Powers P (1987) Development of the human coagulation system in the full-term infant. Blood 70:165-172
13. Andrew M, Paes B, Milner R, Jonston M, Mitchell L, Tollefsen D, Powers P (1988) Development of the human coagulation system in the healthy premature infant. Blood 72:1651-1657
14. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L (1992) Maturation of the hemostatic system during childhood. Blood 80:1998-2005
15. Aronstam A, Dennis B, Friesen MN, Clark WF, Linton AL, Lindsay RM (1978) Ristocetin and the thrombin clotting time. J Clin Pathol 31:1106-1110
16. NCCLS (1998) Collection, transport and processing of blood specimens for coagulation testing and general performance of coagulation assays. In: Standards NCCL (ed) 3rd edn, NCCLS, 940 West Valley Road, Wayne, PA, USA.
17. Adcock DM, Jensen R, Johns CS, Macy PA (2002) Coagulation handbook. Esoterix Coagulation, Austin, TX\